Simple Summary Atherosclerosis is a critical cardiovascular disease associated with the use
of immune checkpoint inhibitors (ICIs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) …

Cancer and cardiovascular diseases (CVD) often share common risk factors, and patients
with CVD who develop cancer are at high risk of experiencing major adverse cardiovascular …

Background Left ventricular stroke work index (LVSWI) and afterload‐related cardiac
performance (ACP) consider left ventricular (LV) afterload and could be better …

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block immune
checkpoints and therefore activate immune cells, allowing them to recognize and attack …

Purpose of review To review recent data regarding the value of echocardiography in the
assessment of patients receiving cancer therapy. Recent findings For the first time …

Background: The increasing use of immune checkpoint inhibitors (ICIs) in the treatment of
both advanced and early stages of various malignancies has resulted in a substantial …

Aims The COVID‐19 infection has been described as affecting myocardial injury. However,
the relation between left ventricular global longitudinal strain (GLS), global circumferential …

Background Immune checkpoint inhibitor (ICI) myocarditis is associated with significant
mortality risk. Electrocardiogram (ECG) changes in ICI myocarditis have strong prognostic …

checkpoint inhibitors(ICIs) have dramatically changed the landscape of cancer care, with
substantial benefits in survival, but carry a clinically important risk of immune-related …

Myocarditis remains a common clinical challenge because of its large array of causative
agents and nonspecific presentation. It may result from a common viral infection, and less …